SPRY2 and acute lymphoblastic leukemia: A substantial increase in the expression levels of MAPK‐negative regulators Dusp6, Etv5 and Spry2 as a consequence of RAS–ERK activation in early NRASG12D transduced cells was also demonstrated but diminished with progression to late pre‐B NRASG12D ALL cells.